ClinicalTrials.gg
Drug

Pitavastatin clinical trials

Also written Livalo.

studies test it
75
open now
6
in phase 3
18
first study started
2004

How each study uses pitavastatin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the pitavastatin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
3 Aug 2009 · LIVALO · NDA 022363 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pitavastatin
53
Pitavastatin (NK-104)
3
Livazo®
2
Pitavastatin calcium
2
Pitavastatin 1 mg daily or 4 mg daily
2

Brand

Livalo
20
Livalo 1mg
1
Livalo 4mg
1
LIVALO 2mg
1

Studies by the year they started

75 studies that test it; most in 2005 (6)

Studies that test pitavastatin, by start year
YearStudies
20041
20056
20065
20074
20085
20093
20106
20116
20121
20133
20143
20153
20165
20172
20184
20193
20201
20212
20221
20231
20241
20254
20265

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
15
Phase 2
1
Phase 3
18
Phase 4
32
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 36 · Other 39

Kowa Research Europe (10) · JW Pharmaceutical (8) · Kowa Research Institute, Inc. (8) · Asan Medical Center (3) · Hoffmann-La Roche (2) · University of California, Irvine (2) · National Medical Research Center for Therapy and Preventive Medicine (1) · Novo Nordisk A/S (1)

Often tested with

Tested in the same studies.

Atorvastatin (9) · Rosuvastatin (4) · Midazolam (3) · Ezetimibe (3) · Sitagliptin (2) · Dabigatran (2) · Pravastatin (2) · Valsartan (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test pitavastatin.

Studies

Open first, then newest update. How each study uses pitavastatin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 75

See all 75 studies that test pitavastatin →

Given beside what is tested · 4 — pitavastatin is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with pitavastatin

Codes

What other systems call pitavastatin · ClinicalTrials.gg INT004019

  • MeSH (NLM) C108475pitavastatinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) M5681Q5F9PPITAVASTATINConfirmed FDA, NLM, Wikidata
  • RxNorm 861634Confirmed FDA, Wikidata
  • Wikidata Q412677pitavastatinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C87751PitavastatinOne source FDA
  • DrugBank DB08860One source Wikidata

Also registered as pitavastatin calcium (UNII IYD54XEG3W · RxNorm 861640) and pitavastatin lactone (UNII ULK88EV7VQ).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.